nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of bevacizumab to chemotherapy in patients with ovarian cancer: a systematic review and meta-analysis of randomized trials
|
Li, J. |
|
2015 |
17 |
9 |
p. 673-683 |
artikel |
2 |
A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
|
Sepúlveda, J. M. |
|
2015 |
17 |
9 |
p. 743-750 |
artikel |
3 |
Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case–control studies
|
Ding, Y. W. |
|
2015 |
17 |
9 |
p. 710-719 |
artikel |
4 |
Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients
|
Deng, J.-H. |
|
2015 |
17 |
9 |
p. 720-726 |
artikel |
5 |
Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations
|
Masuda, T. |
|
2015 |
17 |
9 |
p. 702-709 |
artikel |
6 |
Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients
|
Wang, Y. |
|
2015 |
17 |
9 |
p. 727-736 |
artikel |
7 |
Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis
|
Li, G. |
|
2015 |
17 |
9 |
p. 684-693 |
artikel |
8 |
RAS status in Korean patients with stage III and IV colorectal cancer
|
Lee, W.-S. |
|
2015 |
17 |
9 |
p. 751-756 |
artikel |
9 |
Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel
|
Kar, R. |
|
2015 |
17 |
9 |
p. 737-742 |
artikel |
10 |
The effect of enhanced recovery program for patients undergoing partial laparoscopic hepatectomy of liver cancer
|
He, F. |
|
2015 |
17 |
9 |
p. 694-701 |
artikel |